Human leucocyte alpha-L-fucosidase.
1. Human alpha-L-fucosidase (EC 3.2.1.51) was studied from leucocytes, urine and serum. 2. The leucocyte and urine enzymes are similar in many properties (KM, pH optimum, electrophoretic pattern, heat stability). 3. The serum alpha-L-fucosidase differs from the leucocyte and 4rine enzyme wit,respect to: electrophoretic pattern, pH optimum and heat stapility. 4. The molecular weight of leucocyte alpha-L-fucosidase was determined to be 80 000 +/- 5000. 5. Cu2+, Hg2+ and PCMB are strong inhibitors of leucocyte alpha-L-fucosidase. This inhibition could be completely reversed by beta-mercaptoethanol, indicating that thiol groups are essential for catalytic activity.
D000838:Anions; D002413:Cations, Divalent; D002414:Cations, Monovalent; D002729:Chloromercuribenzoates / Q000494:pharmacology; D004186:Disaccharidases / Q000097:blood*; D004355:Drug Stability; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007501:Iron / Q000494:pharmacology; D007700:Kinetics; D007962:Leukocytes / Q000201:enzymology*; D008623:Mercaptoethanol / Q000494:pharmacology; D005644:alpha-L-Fucosidase / Q000097:blood* / Q000652:urine
D000838:Anions; D002413:Cations, Divalent; D002414:Cations, Monovalent; D002729:Chloromercuribenzoates; D008623:Mercaptoethanol; D007501:Iron; D004186:Disaccharidases; D005644:alpha-L-Fucosidase